Literature DB >> 12829328

Interleukin-10 as a CNS therapeutic: the obstacle of the blood-brain/blood-spinal cord barrier.

Abba J Kastin1, Victoria Akerstrom, Weihong Pan.   

Abstract

Interleukin (IL)-10 exerts beneficial effects on the central nervous system (CNS) after peripheral administration, but its penetration across the blood-brain barrier (BBB) has not been quantified. We show that 125I-IL-10 is stable in circulating blood but does not cross the intact BBB after intravenous delivery. Thus, peripheral IL-10 probably can serve as a CNS therapeutic only when the BBB is disrupted.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12829328     DOI: 10.1016/s0169-328x(03)00167-0

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  12 in total

Review 1.  Concepts for biologically active peptides.

Authors:  Abba J Kastin; Weihong Pan
Journal:  Curr Pharm Des       Date:  2010-10       Impact factor: 3.116

2.  The fasting polypeptide FGF21 can enter brain from blood.

Authors:  Hung Hsuchou; Weihong Pan; Abba J Kastin
Journal:  Peptides       Date:  2007-10-18       Impact factor: 3.750

3.  Role of interleukin-10 (IL-10) in regulation of GABAergic transmission and acute response to ethanol.

Authors:  A Suryanarayanan; J M Carter; J D Landin; A L Morrow; D F Werner; I Spigelman
Journal:  Neuropharmacology       Date:  2016-03-22       Impact factor: 5.250

Review 4.  The therapeutic potential of interleukin-10 in neuroimmune diseases.

Authors:  A J Kwilasz; P M Grace; P Serbedzija; S F Maier; L R Watkins
Journal:  Neuropharmacology       Date:  2014-11-04       Impact factor: 5.250

5.  High cerebrospinal fluid levels of interleukin-10 attained by AAV in dogs.

Authors:  J Pleticha; S A Malkmus; L F Heilmann; S L Veesart; R Rezek; Q Xu; T L Yaksh; A S Beutler
Journal:  Gene Ther       Date:  2014-10-30       Impact factor: 5.250

6.  PEGylation of interleukin-10 for the mitigation of enhanced pain states.

Authors:  Ryan G Soderquist; Erin D Milligan; Jacqueline A Harrison; Raymond A Chavez; Kirk W Johnson; Linda R Watkins; Melissa J Mahoney
Journal:  J Biomed Mater Res A       Date:  2010-06-01       Impact factor: 4.396

7.  Preeclamptic Women Have Decreased Circulating IL-10 (Interleukin-10) Values at the Time of Preeclampsia Diagnosis: Systematic Review and Meta-Analysis.

Authors:  Meryl C Nath; Hajrunisa Cubro; Daniel J McCormick; Natasa M Milic; Vesna D Garovic
Journal:  Hypertension       Date:  2020-10-26       Impact factor: 10.190

8.  Inflammation and blood-brain barrier breach remote from the primary injury following neurotrauma.

Authors:  Nicole M Smith; Marcus K Giacci; Alexander Gough; Charlotte Bailey; Terence McGonigle; Anna M B Black; Thomas O Clarke; Carole A Bartlett; K Swaminathan Iyer; Sarah A Dunlop; Melinda Fitzgerald
Journal:  J Neuroinflammation       Date:  2018-07-07       Impact factor: 8.322

Review 9.  Old Friends, immunoregulation, and stress resilience.

Authors:  Dominik Langgartner; Christopher A Lowry; Stefan O Reber
Journal:  Pflugers Arch       Date:  2018-11-01       Impact factor: 3.657

10.  Interleukin-10: a key cytokine in depression?

Authors:  Susana Roque; Margarida Correia-Neves; Ana Raquel Mesquita; Joana Almeida Palha; Nuno Sousa
Journal:  Cardiovasc Psychiatry Neurol       Date:  2009-08-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.